Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 24, 2022

View Archived Issues

Brain-derived extracellular vesicles participate in the prion-like propagation of tau in tauopathies

EVs and their miRNAs released by inflammatory-primed stem cells may reverse brain inflammation

R8H283 antibody targets multiple myeloma cells through CD98 recognition

GSNOR deficiency tied to pre-eclampsia

CAR T cells targeting GRP78 show activity against acute myeloid leukemia in vivo

Sanofi patents YAP1/TAZ and TEAD interaction inhibitors

Adorx Therapeutics discloses adenosine receptor A2A and/or A2B antagonists

Prodrugs of clopidogrel's active metabolite identified by Shanghai Curegene Pharmaceutical

Femtogenix discovers new antibody-drug conjugates for cancer

Merck & Co. synthesizes new influenza virus Cap-dependent endonuclease inhibitors

v7D, varicella vaccine candidate with promising safety and immunogenicity in nonhuman primates

Financing at Plexium supports progression of pipeline of targeted protein degradation therapies

Jnana selects JNT-517 as development candidate for phenylketonuria

ConserV receives funding to advance pan-coronavirus vaccine candidate UNICOR-v

Identification of novel antifungal and antibacterial compounds

IL-9/ARG1/macrophage axis targeting for the treatment of allergic airway inflammation

GliaPharm and Wyss Center collaborate on new treatments for Alzheimer's disease

Risk SNP for COVID-19 signals protection against HIV

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...